Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet (British edition), 2021-09, Vol.398 (10304), p.957-980 [Peer Reviewed Journal]2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;info:eu-repo/semantics/openAccess ;Attribution ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01330-1 ;PMID: 34450083Full text available |
|
2 |
Material Type: Article
|
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessmentThe Lancet (British edition), 2021-08, Vol.398 (10302), p.772-785 [Peer Reviewed Journal]2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01112-0 ;PMID: 34454675Full text available |
|
3 |
Material Type: Article
|
Organ procurement and transplantation during the COVID-19 pandemicThe Lancet, 2020-05, Vol.395 (10237), p.e95-e96 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31040-0 ;PMID: 32407668Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Haemolytic uraemic syndromeThe Lancet (British edition), 2017-08, Vol.390 (10095), p.681-696 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 12, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30062-4 ;PMID: 28242109Full text available |
|
5 |
Material Type: Article
|
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trialThe Lancet (British edition), 2021-02, Vol.22 (2), p.198-211 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;ISSN: 0140-6736 ;EISSN: 1474-5488 ;EISSN: 1474-547X ;DOI: 10.1016/S1470-2045(20)30641-0 ;PMID: 33476593Full text available |
|
6 |
Material Type: Article
|
Temporary circulatory support for cardiogenic shockThe Lancet (British edition), 2020-07, Vol.396 (10245), p.199-212 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31047-3Full text available |
|
7 |
Material Type: Article
|
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trialThe Lancet (British edition), 2022-07, Vol.400 (10346), p.104-115 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00537-2 ;PMID: 35810756Full text available |
|
8 |
Material Type: Article
|
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trialThe Lancet (British edition), 2023-01, Vol.401 (10371), p.105-117 [Peer Reviewed Journal]2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02420-5 ;PMID: 36495879Full text available |
|
9 |
Material Type: Article
|
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyThe Lancet (British edition), 2021-03, Vol.397 (10277), p.892-901 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00224-5 ;PMID: 33676628Full text available |
|
10 |
Material Type: Article
|
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyThe Lancet (British edition), 2019-04, Vol.393 (10179), p.1453-1464 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32111-1 ;PMID: 30765123Full text available |
|
11 |
Material Type: Article
|
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trialThe Lancet (British edition), 2018-02, Vol.391 (10121), p.659-667 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 17, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)33108-2 ;PMID: 29241979Full text available |
|
12 |
Material Type: Article
|
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityThe Lancet (British edition), 2022-01, Vol.399 (10319), p.61-116 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01701-3 ;PMID: 34863359Full text available |
|
13 |
Material Type: Article
|
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialThe Lancet (British edition), 2021-06, Vol.397 (10293), p.2476-2486 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00788-1 ;PMID: 34010611Full text available |
|
14 |
Material Type: Article
|
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsThe Lancet (British edition), 2020-07, Vol.396 (10244), p.121-128 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30748-0 ;PMID: 32446323Full text available |
|
15 |
Material Type: Article
|
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trialsThe Lancet (British edition), 2020-09, Vol.396 (10254), p.819-829 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31824-9 ;PMID: 32877652Full text available |
|
16 |
Material Type: Article
|
Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort studyThe Lancet (British edition), 2020-08, Vol.396 (10250), p.545-552 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30733-9 ;PMID: 32828186Full text available |
|
17 |
Material Type: Article
|
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participantsThe Lancet (British edition), 2020-11, Vol.396 (10261), p.1511-1524 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Attribution ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31859-6 ;PMID: 33160572Full text available |
|
18 |
Material Type: Article
|
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyThe Lancet (British edition), 2016-04, Vol.387 (10027), p.1531-1539 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 9, 2016 ;2016. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)00562-6 ;PMID: 26948433 ;CODEN: LANCAOFull text available |
|
19 |
Material Type: Article
|
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)The Lancet (British edition), 2023-01, Vol.401 (10370), p.25-37 [Peer Reviewed Journal]2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02302-9 ;PMID: 36493791Full text available |
|
20 |
Material Type: Article
|
Heart failure drug treatmentThe Lancet (British edition), 2019-03, Vol.393 (10175), p.1034-1044 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31808-7 ;PMID: 30860029Full text available |